rhG-CSF
(SunGran)
The Recombinant Human Granulocyte Stimulating Factor is
a genetically
engineered protein drug. It is a synthetic (man-made)
version of a substance naturally produced by the body that
stimulates the production and growth of certain white blood
cells. White blood cells protect the body by fighting bacteria
that may cause infection. Most of the time chemotherapy
has myelotoxicity
and can lower the number of white
blood cells. rhG-CSF helps to encourage the release
and maturation of CFU-G into the blood from the bone
marrow that is why it is recommended during chemo-therapy
treatment. The rhG-CSF was launched in 2001. It has already
taken 30% of the market share in Shanghai. The company would
like to sell more of it all over the country.
Formulated SunGran is an aqueous solution colorless, clear
and sterile. Each vial of SunGran contains 75, 150, or 300μg
of rhG-CSF. The SunGran injection also contains 10mM acetic
acid- sodium-acetate buffer, 5% mannitol and 0.004%Tween-80,
and it is at pH 4.00.
SunGran should be administrated 24 to 48 hours after chemotherapy
ends. Sungran is given as a single daily injection by SC
bolus injection or by a short IV infusion. The dosage of
SunGran given to a patient is according to the strength
and the decreasing degree of the neutral-cell. For those
suffering an intense chemical treatment or suffering an
obvious decrease of granular leucocytes, 2.5μg/kg weight/day
dosage continuing for 7days or more until the recovery of
the neutral granular leucocytes to 5000/mm3 is
commonly suitable; for those with a lower dosage of the
chemical medicine and estimated with unserious marrow inhibition,
1.25μg/kg weight/day dosage for preventing from the decrease
of the neutral granular leucocytes until the quantity of
the neutral granular leucocytes considered stable within
a safety range is commonly suitable; and for those having
an obvious decrease of the neutral granular leucocytes after
the chemical treatment (the quantity of the neutral granular
leucocytes<1000/ mm3), 5μg/kg weight/day dosage
until the recovery of the neutral granular leucocytes to
5000/ mm3 is commonly suitable. When the quantity
of the neutral granular leucocytes become stable, please
stop the administration of SunGran and watch the state of
the illness.
|